ECONSALUT

The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom The ...

Ending Medical Reversal Improving Outcomes, Saving Lives

Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment. This paper lays out a coherent framework for t...

The Promise and Price of Cellular Therapies The op-ed of The New Yorker provides a clear understanding of the development of CAR-T therapi...

Trends in clinical success rates and therapeutic focus Clinical failure rates from phase I to drug launch remain at 93%. If we look a...

Behavioral Economics and Healthy Behaviors Key Concepts and Current Research A reference book on the topic that tries to put theory into ...

How Do We Measure the Value of Health?

Causal Inference BIG DATA I REAL WORLD DATA EN L'ANÀLISI DE LA UTILIZACIÓ, SEGURETAT I EFECTIVITAT DE MEDICAMENTS, TECNOLOGIES I INTERV...

What Is Enough? Sufficiency, Justice, and Health The capability approach is an alternative to welfarist and extra-welfarist approaches to ...

A practical guide to episode groupers for cost-of-illness analysis in health services research Summary of analytic components in selected...

BEHAVIORAL INSIGHTS. BASIC TOOLKIT AND ETHICAL GUIDELINES FOR POLICY MAKERS This OECD report is really helpful. It tries to provide a conc...

Eric Topol on making healthcare more human  A weekly conversation that looks at the way technology is changing our economies, societies a...

World Preview 2019,Outlook to 2024 If worldwide Total Prescription Drug Sales (2010-2024) increase 6,9% every year between 2019 to 2024 th...

" Studies that find little impact of health care on health are cross-sectional. Studies that find a big impact...